三、对公司的影响 公司本次取得土地使用权后，将用于公司募投项目"金山工厂升级改造项目"的建设和实施。本次签署合 同将有力地推动募投项目实施进度，提升募集资金使用效益，有利于公司的持续长远发展，为公司股东 带来回报。本次签署合同不影响公司现有业务的正常开展，不会对公司财务状况及经营成果产生重大影 响，不存在损害上市公司和全体股东利益的情形。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 一、金山工厂改造升级项目概述 上海天承科技股份有限公司（以下简称"公司"）于2025年7月11日召开了第二届董事会第十九次会议及 第二届监事会第十三次会议，审议通过了《关于变更部分募投项目的议案》，同意终止募投项目"珠海 研发中心建设项目"并将原计划投入的募集资金及其孳息8,360.17万元用于新项目"金山工厂升级改造项 目"。本次变更后，金山工厂升级改造项目的实施主体为公司全资子公司上海天承化学有限公司（以下 简称为"天承化学"）；项目投资总额为12,400.57万元，主要用于于土地购置、工程建设等。上述议案已 于2025年7月28日召开的2 ...

Core Viewpoint - The board of directors of Suzhou Xinyi Alloy Tool Co., Ltd. held its 17th meeting of the 5th session, approving several key proposals related to the company's financial reporting, fundraising, profit distribution, governance structure, and operational strategies [1][2][3][4][5][6]. Group 1: Meeting and Voting Results - The meeting was held on August 26, 2025, with all 7 directors present, ensuring compliance with relevant laws and regulations [1]. - All proposals were passed unanimously with 7 votes in favor, and no votes against or abstentions [2][3][4][5][6]. Group 2: Financial Reporting and Fundraising - The 2025 semi-annual report was approved, reflecting the company's financial status and operational results accurately [2]. - A special report on the storage and actual use of raised funds was approved, confirming compliance with regulations and proper usage of funds [2]. - The profit distribution plan for the first half of 2025 was approved, considering the company's profitability and cash flow [3]. Group 3: Governance and Structural Changes - The proposal to abolish the supervisory board and amend the company's articles of association was approved, aligning with new regulatory requirements [3]. - The company plans to increase capital in its wholly-owned subsidiary, Wuhan Xinyi Alloy Tool Co., Ltd., by up to 40 million yuan for project implementation [4]. Group 4: Audit and Risk Management - The company intends to change its accounting firm to Rongcheng Accounting Firm for the 2025 fiscal year [5]. - A proposal to engage in foreign exchange hedging activities with a limit of up to 70 million USD was approved [5]. Group 5: Operational Strategies - The board approved a semi-annual evaluation report on the "Quality Improvement and Efficiency Enhancement" action plan, aimed at enhancing operational efficiency and market competitiveness [6]. - The board agreed to convene the second extraordinary general meeting of 2025, utilizing both in-person and online voting methods [6].

Summary of Key Points Core Viewpoint - The company is increasing the implementation subjects for certain fundraising projects and establishing a dedicated fundraising account to enhance the efficiency of fund usage and project execution, aligning with its overall development strategy [4][5][6]. Fundraising Basic Information - The company was approved to issue 30,707,070 shares at a price of 5.08 RMB per share, raising a total of 1,559,919,156 RMB, with a net amount of 1,418,966,238.97 RMB after deducting issuance costs [1]. Fund Usage Status - As of June 30, 2025, the total investment for the projects is 75,678.02 million RMB, with 75,000.00 million RMB already invested, indicating a significant progress in fund utilization [2]. New Implementation Subject - The company plans to establish a wholly-owned subsidiary, Ningbo Embodied Intelligent Robot Innovation Center Co., Ltd., to serve as the new implementation subject for the project "Industrial Digital Product Technology Upgrade Application and Medical Robot R&D" [3][4]. New Fundraising Account - A new fundraising account will be established to ensure proper management and usage of the funds, with agreements signed between the new subject, the company, and the commercial bank [4][5]. Reasons and Impact of Changes - The changes are driven by the actual needs of the company's business development, aiming to facilitate project execution without altering the investment direction or project content, thus ensuring resource allocation efficiency [4][6]. Review Procedures and Opinions - The board approved the changes without needing a shareholder meeting, and the supervisory board confirmed that the changes comply with relevant regulations and will not adversely affect the company's financial status or shareholder interests [4][5].

Summary of Key Points Core Viewpoint - The company plans to use part of the raised funds to provide interest-free loans to its wholly-owned subsidiary for the implementation of fundraising projects, which has been reviewed and approved by the sponsor institution [1][9]. Fundraising Overview - The company raised a total of RMB 1,109.25 million through its initial public offering, with a net amount of RMB 994.64 million after deducting issuance costs [1]. - The total planned investment for the fundraising projects is RMB 1,771.79 million, with the company intending to allocate RMB 994.64 million from the raised funds [2]. Use of Funds - The company previously provided an interest-free loan of RMB 50 million to its subsidiary Shenzhen Kexing Pharmaceutical for the "R&D Center Upgrade Project" [2][3]. - The current plan includes an additional interest-free loan of RMB 20 million to the same subsidiary for ongoing R&D projects, bringing the total loan amount to RMB 120 million [4][5]. Project Progress - As of June 30, 2025, the cumulative investment in the R&D Center Upgrade Project is RMB 347.46 million, with RMB 290.63 million already utilized, resulting in a shortfall of RMB 56.83 million [4]. - The remaining balance in the dedicated fundraising account for this project is RMB 73.96 million, which includes net income from financial products and bank interest [4]. Financial Data of the Subsidiary - As of December 31, 2024, the subsidiary reported total assets of RMB 535.61 million, net assets of RMB 278.31 million, operating income of RMB 316.77 million, and net profit of RMB 51.75 million [7]. Approval Process - The use of funds for the interest-free loan has been approved by the company's board and supervisory board, complying with relevant regulations [9].

西南证券股份有限公司 关于广东松发陶瓷股份有限公司使用募集资金向全资子公司增 资暨全资子公司向全资孙公司增资以实施募投项目的核查意见 西南证券股份有限公司（以下简称"西南证券"或"独立财务顾问"）作为 广东松发陶瓷股份有限公司（以下简称"松发股份"、"上市公司"或"公司"） 的独立财务顾问，根据《上市公司募集资金监管规则》《上海证券交易所上市公 司自律监管指引第 1 号——规范运作》等相关法律法规和规范性文件的规定，对 松发股份使用募集资金向全资子公司增资暨全资子公司向全资孙公司增资以实 施募投项目的事项进行了审慎核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意广东松发陶瓷股份有限公司发行股 份购买资产并募集配套资金注册的批复》（证监许可〔2025〕1032 号），公司向 特定对象发行人民币普通股（A 股）109,080,992 股，发行价格为人民币 36.67 元 /股，募集资金总额为人民币 3,999,999,976.64 元，扣除各项发行费用人民币 通合伙）审验并出具了中汇会验[2025]10382 号《验资报告》。 为规范公司募集资金的管理和使用，保护投资者的权益，根据 ...

Summary of Key Points Core Viewpoint - The company intends to use part of the raised funds to provide loans to its wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd., to implement its fundraising projects, which aligns with its overall strategic planning and long-term interests [1][8]. Fundraising Basic Situation - The company raised a total of RMB 1,047,987,200.00 by issuing 16.64 million shares at RMB 62.98 per share, with a net amount of RMB 920,537,016.65 after deducting issuance costs [1][2]. Management and Use of Raised Funds - All raised funds have been deposited into a special account approved by the board of directors, and a tripartite supervision agreement has been signed with the sponsor and the supervising bank [2][9]. Fundraising Project Adjustments - The company has made adjustments to its fundraising projects, including extending the implementation period for certain projects to July 2027 and terminating others, such as the "High Precision PGA/ADC Signal Chain Chip Upgrade and Industrialization Project" [3][5]. Loan Provision Details - The company plans to provide a loan of up to RMB 35 million to its subsidiary, Jinghua Zhixin, to ensure the smooth implementation of the "Research and Development Center Construction Project" [5][6]. Loan Management and Usage - The loan will be managed in a dedicated account and can only be used for the specified fundraising projects, with the interest rate based on the latest one-year Loan Prime Rate (LPR) [6][9]. Approval Process - The board of directors approved the loan provision on July 29, 2025, and this decision falls within the board's authority, thus not requiring shareholder approval [7][9]. Sponsor's Verification Opinion - The sponsor has verified that the loan provision complies with relevant regulations and does not harm the interests of the company or its shareholders, ensuring that the fundraising plan remains intact [9][10].

Group 1 - The company, Jinghua Micro (688130.SH), announced the convening of its second board meeting on July 29, 2025, to review and approve the proposal for using part of the raised funds to provide loans to its wholly-owned subsidiary, Shenzhen Jinghua Zhixin Microelectronics Co., Ltd. [1] - The approved loan amount is up to 35 million yuan, aimed at implementing the fundraising project for the "Research and Development Center Construction Project" [1]

Core Viewpoint - The company has added a wholly-owned subsidiary as an implementation entity for part of its fundraising projects and opened a new fundraising account, which is aimed at improving the efficiency of fund usage and ensuring the progress of the investment project [1][4]. Fundraising Basic Situation - The company issued 46.38 million shares at a price of RMB 17.39 per share, raising a total of RMB 806.55 million. After deducting issuance costs of RMB 79.00 million, the net amount raised is RMB 727.55 million [1][2]. New Implementation Entity for Fundraising Projects - The original implementation entity for the "Wuhan Production Base Construction Project" was the wholly-owned subsidiary, Hubei Ping An Electric Industry Co., Ltd. The company has added Hubei Taikai Aneng Technology Co., Ltd. as a new implementation entity, maintaining the original fundraising amount of RMB 122.92 million for the project [2][3]. Basic Situation of New Implementation Entity - The new implementation entity is involved in various manufacturing and sales activities, including mica products, electrical equipment, and hardware products [3]. Fundraising Management After Adding New Entity - The company will open a special fundraising account for the new implementation entity and sign a four-party supervision agreement to monitor the storage and usage of the raised funds [3][4]. Purpose and Impact of Adding New Implementation Entity - The addition of the new implementation entity is based on the actual needs of the company's business development, which is expected to enhance the efficiency of fund usage and ensure the timely progress of the investment project [4][5]. Review and Approval Procedures - Both the board of directors and the supervisory board have approved the addition of the new subsidiary and the opening of the fundraising account, confirming that the decision aligns with the company's needs and does not harm shareholder interests [4][5]. Sponsor's Verification Opinion - The sponsor has verified that the addition of the new subsidiary and the opening of the fundraising account have been approved by the necessary corporate governance bodies and comply with relevant regulations [5].

Summary of Key Points Core Viewpoint - The company intends to use self-raised funds to pay for investment project expenses and subsequently replace these with raised funds, ensuring efficient use of capital and smooth project implementation [1][7][8]. Group 1: Fundraising and Allocation - The company successfully raised a total of RMB 2,499,999,974.82 through a non-public issuance of 69,098,949 shares at RMB 36.18 per share, with a net amount of RMB 2,487,483,821.84 after deducting issuance costs [1]. - As of November 30, 2023, the remaining balance for the original investment project was RMB 758.205 million, which will be redirected to a new oil and gas technology service project [2]. Group 2: Project Management and Adjustments - The company held a temporary shareholders' meeting on January 18, 2024, to approve the change of use for the remaining funds from the original project to the new project [2]. - The company has extended the deadline for the digital transformation phase one project and the oil and gas technology service project to December 31, 2027, without changing the investment amounts [3]. Group 3: Use of Self-raised Funds - The company plans to use self-raised funds for initial payments on investment projects, which will later be replaced by raised funds to enhance efficiency [4][5]. - The rationale for using self-raised funds includes compliance with banking regulations, operational efficiency, and cost reduction in procurement [4][5]. Group 4: Operational Procedures - A detailed operational process has been established for using self-raised funds, including contract signing, payment applications, and monthly reporting to the sponsor institution [6]. - The financial department will maintain a special ledger to track the replacement of self-raised funds with raised funds, ensuring transparency and accountability [6]. Group 5: Approval and Oversight - The board of directors and the supervisory board have approved the use of self-raised funds, confirming that the process adheres to legal and regulatory requirements [7]. - The sponsor institution has conducted a review and found no issues with the company's plan to use self-raised funds, ensuring that shareholder interests are protected [7][8].

本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 证券代码：300286 证券简称：安科瑞 公告编号：2025-041 安科瑞电气股份有限公司 第六届董事会第十四次会议决议的公告 《关于使用银行承兑汇票等方式支付募集资金投资项目所需资金并以募集资金 等额置换的公告》的具体内容详见中国证监会指定创业板信息披露网站巨潮资讯网 （http://www.cninfo.com.cn）。 安科瑞电气股份有限公司（以下简称"公司"）于2025年5月9日以书面送达或 电子通讯方式向全体董事发出了关于召开第六届董事会第十四次会议（以下简称"会 议"）的通知,会议于2025年5月19日以通讯方式召开。会议应出席董事9人，实际出 席董事9人。本次会议由董事长周中先生召集并主持。本次会议的召集、召开符合《中 华人民共和国公司法》、《安科瑞电气股份有限公司章程》的有关规定。 表决结果：同意 9 票，反对 0 票，弃权 0 票。 特此公告。 与会董事审议通过了如下议案： 安科瑞电气股份有限公司董事会 一、审议通过了《关于使用募集资金向全资子公司增资以实施募投项目的议案》 为提高募集资金使用 ...